GARDEN CITY, NY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced the ...
The three months ended March 31, 2024, marked a continuation of the transformation of ProPhase Labs. As the expansion plans at its wholly owned subsidiary, Pharmaloz Manufacturing, gain momentum, the ...
ProPhase Labs' recent 52-week low is reflective of broader challenges faced by the company, as highlighted by several InvestingPro metrics and tips. The company's market capitalization stands at a ...
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re ...
Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...
UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH) and European biotechnology group Advanced Biological Laboratories S.A. (ABL) announced Friday they have entered into a non-binding Letter of Intent ...
UNIONDALE, NY, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the "Company” or "ProPhase”), a next generation biotech, genomics, and consumer products company, today announced ...
ProPhase has been collaborating with Crown Medical Collections to pursue over $150 million in uncollected COVID-19 testing receivables from more than 1,100 insurance companies. Crown’s legal strategy ...
ProPhase Labs Inc. (PRPH) reported its second-quarter earnings for 2025, showcasing a narrower-than-expected loss but significant revenue shortfall. The company posted an earnings per share (EPS) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results